Open Access

Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway

Qing Su

Qing Su

Department of Orthopedic Oncology, Yantai Shan HospitalYantai, China
Search for this author on
Sciendo|Google Scholar
Su, Qing
, 
Baolin Xu

Baolin Xu

Department of Orthopedics, The Second Affiliated Hospital Zhejiang University School of MedicineHangzhou, China
Search for this author on
Sciendo|Google Scholar
Xu, Baolin
, 
Zhoubin Tian

Zhoubin Tian

Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityJinan, China
Search for this author on
Sciendo|Google Scholar
Tian, Zhoubin
 and 
Ziling Gong

Ziling Gong

Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalShanghai, China
Search for this author on
Sciendo|Google Scholar
Gong, Ziling
  
Apr 13, 2022
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Apr 13, 2022
Page range: 389 - 402
Accepted: Dec 14, 2021
DOI: https://doi.org/10.2478/acph-2022-0026
Keywords
© 2022 Qing Su et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Pharmacy, Pharmacy, other
Journal RSS Feed